SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales moved up 26.71% to Rs. 1424.93 millions for the March 2024 quarter as compared to Rs. 1124.60 millions during the year-ago period.An average growth of 48.03% was recorded for the quarter ended March 2024 to Rs. 185.97  millions from Rs. 125.63 millions.OP of the company witnessed a marginal growth to 254.02 millions from 205.43 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1424.93 1124.60 26.71 5805.50 5103.09 13.76 5805.50 5103.09 13.76
Other Income 70.19 39.46 77.88 344.22 224.84 53.10 344.22 224.84 53.10
PBIDT 254.02 205.43 23.65 1343.30 1116.50 20.31 1343.30 1116.50 20.31
Interest 4.99 11.48 -56.53 14.63 20.29 -27.90 14.63 20.29 -27.90
PBDT 249.03 193.95 28.40 1328.67 1096.21 21.21 1328.67 1096.21 21.21
Depreciation 26.86 24.13 11.31 106.25 91.66 15.92 106.25 91.66 15.92
PBT 222.17 169.82 30.83 1222.42 1004.55 21.69 1222.42 1004.55 21.69
TAX 36.20 44.19 -18.08 289.38 275.56 5.02 289.38 275.56 5.02
Deferred Tax -4.93 10.11 -148.76 34.95 15.86 120.37 34.95 15.86 120.37
PAT 185.97 125.63 48.03 933.04 728.99 27.99 933.04 728.99 27.99
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 17.83 18.27 -2.41 23.14 21.88 5.76 23.14 21.88 5.76

Lincoln Pharma Share Price

621.90 10.85 (1.78%)
19-Jun-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.95
Dr. Reddys Lab 1264.85
Cipla 1353.50
Zydus Lifesciences 1074.85
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: